关键词：内分泌系统；研究内分泌交易；生化激素；细胞；生理功能；内分泌失调；内分泌紊乱；糖尿病
摘 要：Endocrinology deals with the study of the endocrine system, including the biochemical and physiological functions of the hormones, cells, and tissues of the endocrine glands. Endocrine disorders can be broadly subdivided into three categories: endocrine gland hyposecretion, which causes hormone deficiency, endocrine gland hypersecretion, which causes excess hormone secretion, and tumors in the endocrine gland. The endocrine disorders considered for the present report include diabetes, human growth hormone deficiency, thyroid disorders, and male hypogonadism.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Key buying criteria

PART 06: Pipeline portfolio

PART 07: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 08: Market segmentation by application

PART 09: Global diabetes drugs market

Introduction

Market overview

Market drivers

Market challenges

Market trends

Vendor analysis of global diabetes drugs market

PART 10: Global testosterone replacement therapy

market

Introduction

Market overview

Market drivers

Market challenges

Market trends

Vendor analysis of global testosterone replacement

therapy market

PART 11: Global human growth hormone market

Introduction

Market overview

Market drivers

Market challenges

Market trends

Vendor analysis of global human growth hormone

market

PART 12: Global thyroid hormone disorder drugs market

Market overview

Market drivers

Market challenges

Market trends

Vendor analysis of global thyroid disorder drugs

market

PART 13: Geographical segmentation

Global endocrinology drugs market by geographical

segmentation 2015-2020

Endocrinology drugs market in Americas

Endocrinology drugs market in EMEA

Endocrinology drugs market in APAC

PART 14: Market drivers

Increase in prevalence of endocrine hormone-related

diseases

Promising drug pipeline

Advances in drug delivery technology

Stringent regulatory conditions for biosimilar drugs

PART 15: Impact of drivers

PART 16: Market challenges

Generic erosion

Side effects and associated risks

Rising concerns in scientific community

Low diagnosis rate

PART 17: Impact of drivers and challenges

PART 18: Market trends

Development of drugs with novel mechanism and

technologies

Strategic alliances and M&A

Increased awareness

Increase in outsourcing

PART 19: Vendor landscape

Competitive scenario

Market share analysis 2015

Novo Nordisk

Sanofi

Merck

Eli Lilly

AstraZeneca

AbbVie

Other prominent vendors

PART 20: Appendix

List of abbreviations

PART 21: Explore Technavio